CHD-TV Logo
FDA: Vaccines and Related Biological Products Advisory Committee (VRBPAC)

FDA: Vaccines and Related Biological Products Advisory Committee (VRBPAC)

The FDA VRBPAC will be convening on the topic of amending the Moderna COVID-19 mRNA vaccine EUA to allow it's use in the 6 through 17 years age group, as well as the 6 month through 5 years age group. The Pfizer-BioNtech COVID-19 mRNA vaccine will also be considered in amending it's EUA to include use among infants and children 6 months through 4 years old.

Live-blog of the event by Dr. Meryl Nass.

videos